Abstract 2163P
Background
In France, cancer is the leading cause of death among men and the second leading cause among women. Currently, supportive care provided to cancer patients in community pharmacies are heterogeneous across the country. In order to structure and standardize pharmaceuticalsupportfor all cancer patients in primary care, TotumLab foundation has created the OncoPharma certification.
Methods
The OncoPharma certification is based on a framework that covers the activities of dispensing treatments andsupportingcancer patients, caregivers and relatives, from the time of diagnosis, during and after cancer, by the entire pharmacy team. The framework presents certified characteristics, the way to implement them, as well as documentary ressources and requested internal controls to ensure compliance. The development of the certification framework is the result of a multidisciplinary collaborative effort, bringing together all healthcare professionals involved in cancer patients care. The OncoPharma certification is accessible to all community pharmacies in France.
Results
In the certification framework, patient care is structured around 14 operational characteristics that are proposed and adapted to each individual situation. Since June 2022, the OncoPharma certification framework has been accredited by the French accreditation committee (COFRAC). This document allowed for the publication of the first clinical guideline for the management of cancer patients in community pharmacies by the Francophone Association of Supportive Oncology Care (AFSOS). As of April 2023, two pharmacies have been certified under OncoPharma, and over 40 others are in the process of certification.
Conclusions
This innovative project is the result of collective and multidisciplinary work to improve the quality of life of patients living with cancer. It promotes communication and coordination among healthcare professionals, as well as training and upskilling of pharmacy teams. This project is part of the continuous improvement and value creation in healthcare. Thanks to the Oncopharma certification, the community pharmacist plays a central role in the care of people with cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
TotumLab.
Funding
TotumLab.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2130P - ATTITUDE - ATTrition In longiTUDinal studiEs of cancer survivors (CS): Can we improve the experience of patients (pts)?
Presenter: Camila Chiodi
Session: Poster session 07
2131P - Real-life experiences from a late effects clinic: An investigation of health-related quality of life in Danish cancer survivors
Presenter: Lærke Tolstrup
Session: Poster session 07
2132P - Unmet needs, quality of life, and financial toxicity in survivors of lung cancer
Presenter: Josephine Feliciano
Session: Poster session 07
2133P - Sleep disorders: Evolution in time in early breast cancer (EBC)
Presenter: Blanca Cantos
Session: Poster session 07
2134P - Self-reported late effects, need for information and follow-up in long-term Hodgkin lymphoma survivors
Presenter: Lise Willumsen
Session: Poster session 07
2135P - Impact of geriatric assessment (GA) and geriatric 8(G8)-based targeted interventions on the quality of life (QoL) in older Asian adults with cancer
Presenter: Jia Li Low
Session: Poster session 07
2136P - Prostate cancer supportive care (PCSC) program for patients and partners: A model for meeting an unmet need for PC patients
Presenter: Celestia Higano
Session: Poster session 07
2137P - Impact of supportive care on the quality of life (QoL) of hospitalized cancer patients (pts)
Presenter: Judit Sanz Beltran
Session: Poster session 07
2138P - Time toxicity of palliative chemotherapy in a geriatric oncology population
Presenter: Christopher Cronin
Session: Poster session 07
2139P - Quality of life in adult cancer survivors (QLACS) in Spain: Study of its clinical characteristics and use of social media for oncological information
Presenter: Maria Cornide Santos
Session: Poster session 07